Spiriva Respimat 2.5microg/dose inhalation soln
BNF presentation 0301020Q0BBACAC within chapter Respiratory System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0301020Q0BBACAC
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
200,239
NHS spend (£)
£4,806,082.26
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 24,706 |
| February 2025 | 210 |
| December 2024 | 7,217 |
| November 2024 | 27,332 |
| October 2024 | 28,899 |
| September 2024 | 117 |
| August 2024 | 2,097 |
| July 2024 | 28,785 |
| May 2024 | 6,397 |
| July 2021 | 11,938 |
| June 2021 | 7,623 |
| December 2020 | 25,658 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 399 | No data available |
| Unknown pharmacy | 384 | No data available |
| Unknown pharmacy | 379 | No data available |
| Unknown pharmacy | 289 | No data available |
| Unknown pharmacy | 285 | No data available |
| Unknown pharmacy | 285 | No data available |
| Unknown pharmacy | 284 | No data available |
| Unknown pharmacy | 283 | No data available |
| Unknown pharmacy | 280 | No data available |
| Unknown pharmacy | 275 | No data available |